RT @sitcancer: #JITC Research: Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gast…
1,926 followers
19,108 followers
#JITC Research: Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial https://t.co/HjWLnbjr4z https://t.co/sw
81 followers
RT @sitcancer: #JITC Research: Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gast…
1,926 followers
RT @sitcancer: #JITC Research: Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gast…